Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Zhejiang Shouxiangu Pharmaceutical Co Ltd
Pre-Tax Income
Zhejiang Shouxiangu Pharmaceutical Co Ltd
Pre-Tax Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
|
Pre-Tax Income
¥132.6m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Hengan International Group Company Ltd
HKEX:1044
|
Pre-Tax Income
¥3.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-3%
|
|
|
Proya Cosmetics Co Ltd
SSE:603605
|
Pre-Tax Income
¥1.8B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
|
Pre-Tax Income
¥608.4m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
By-health Co Ltd
SZSE:300146
|
Pre-Tax Income
¥1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
3%
|
|
|
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
Pre-Tax Income
¥2.4B
|
CAGR 3-Years
26%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Zhejiang Shouxiangu Pharmaceutical Co Ltd
Glance View
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the breeding, cultivation, processing, and sale of Chinese herbal pieces and health food. The company is headquartered in Jinhua, Zhejiang and currently employs 1,026 full-time employees. The company went IPO on 2017-05-10. The firm's main products include ganoderma lucidum spore powder, Tiepi Fengdou granule, ganoderma extract products and fresh dendrobium officinales, among others. The firm mainly operates its businesses in domestic markets through wholesaling and direct sales.
See Also
What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's Pre-Tax Income?
Pre-Tax Income
132.6m
CNY
Based on the financial report for Sep 30, 2025, Zhejiang Shouxiangu Pharmaceutical Co Ltd's Pre-Tax Income amounts to 132.6m CNY.
What is Zhejiang Shouxiangu Pharmaceutical Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
0%
Over the last year, the Pre-Tax Income growth was -43%. The average annual Pre-Tax Income growth rates for Zhejiang Shouxiangu Pharmaceutical Co Ltd have been -18% over the past three years .
